OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-PLN antibodies

Anti-PLN Antibody

div

Specifications Citations Related Products Product Documents
SKU Description Amount Price Availability*  
TA318818
  • PLN / Phospholamban Goat Polyclonal (N-Terminus) Antibody
50ug 345 3-7 Days
Add to Shopping Cart
IHC(1)

OriGene Data

ImmunogenSynthetic peptide KVQYLTRSAIRR-C from the N-terminus of human PLN / Phospholamban (NP_002658.1). Percent identity by BLAST analysis: Human, Monkey, Marmoset, Mouse, Rat, Panda, Bat, Bovine, Dog, Horse, Rabbit, Pig, Opossum (100%); Gorilla, Gibbon, El ...
Clone Name Isotype
Species ReactivityBovine, Human, Porcine, Rat Concentration0.5 mg/ml
Guaranteed Application *IHC Suggested DilutionsELISA (1:8000), IHC-P (3.75 µg/ml), WB (0.01 - 0.03 µg/ml)
BufferTris-buffered saline, pH 7.3, 0.5% BSA, 0.02% sodium azide
Purification Immunoaffinity Chromatography
Note Human PLN / Phospholamban.

Reference Data

Target NameHomo sapiens phospholamban (PLN)
Alternative NameCMD1P; CMH18; PLB
Database LinkNP_002658
Entrez Gene 5350 Human
Entrez Gene 64672 Rat
Function
Related PathwayTransmembrane Calcium signaling pathwayDilated cardiomyopathy

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

IHC Image
Human Heart: Formalin-Fixed, Paraffin-Embedded (FFPE)

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title